Risks and benefits associated with antibiotic use for acute respiratory infections: a cohort study
- PMID: 23508604
- PMCID: PMC3601395
- DOI: 10.1370/afm.1449
Risks and benefits associated with antibiotic use for acute respiratory infections: a cohort study
Abstract
Purpose: Antibiotics are frequently prescribed for acute nonspecific respiratory infections (ARIs), presumably to avoid small risks of progression to serious bacterial illness. However, even low risks of associated adverse drug events could result in many such events at the population level. Our objective was to assess the risks and benefits of antibiotic use in a cohort of patients with ARIs, comparing outcomes of patients who were prescribed antibiotics with outcomes of patients not receiving antibiotics.
Methods: We used a June 1986 to August 2006 cohort of adult patients with ARI visits from a UK primary care database. Exposure was an antibiotic prescribed with the visit. Primary outcomes were hospitalization within 15 days for (1) severe adverse drug events (hypersensitivity, diarrhea, seizure, arrhythmia, hepatic or renal failure), and (2) community-acquired pneumonia.
Results: The cohort included 1,531,019 visits with an ARI diagnosis; prescriptions for antibiotics were given in 65% of cases. The adjusted risk difference for treated vs untreated patients per 100,000 visits was 1.07 fewer adverse events (95% CI, -4.52 to 2.38; P = .54) and 8.16 fewer pneumonia hospitalizations (95% CI, -13.24 to -3.08; P = .002). The number needed to treat to prevent 1 hospitalization for pneumonia was 12,255.
Conclusions: Compared with patients with ARI who were not treated with antibiotics, patients who were treated with antibiotics were not at increased risk of severe adverse drug events and had a small decreased risk of pneumonia hospitalization. This small benefit from antibiotics for a common ambulatory diagnosis creates persistent tension; at the societal level, physicians are compelled to reduce antibiotic prescribing, thus minimizing future resistance, whereas at the encounter level, they are compelled to optimize the benefit-risk balance for that patient.
Figures
Similar articles
-
Application of a simple point-of-care test to reduce UK healthcare costs and adverse events in outpatient acute respiratory infections.J Med Econ. 2020 Jul;23(7):673-682. doi: 10.1080/13696998.2020.1736872. Epub 2020 Apr 7. J Med Econ. 2020. PMID: 32259465
-
Accuracy of pneumonia hospital admissions in a primary care electronic medical record database.Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):659-65. doi: 10.1002/pds.3207. Epub 2012 Feb 28. Pharmacoepidemiol Drug Saf. 2012. PMID: 22374684 Free PMC article. Clinical Trial.
-
Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons.JAMA Netw Open. 2018 Jun 1;1(2):e180243. doi: 10.1001/jamanetworkopen.2018.0243. JAMA Netw Open. 2018. PMID: 30646067 Free PMC article.
-
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.Evid Based Child Health. 2013 Jul;8(4):1297-371. doi: 10.1002/ebch.1927. Evid Based Child Health. 2013. PMID: 23877944 Review.
-
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD007498. doi: 10.1002/14651858.CD007498.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2017 Oct 12;10:CD007498. doi: 10.1002/14651858.CD007498.pub3. PMID: 22972110 Free PMC article. Updated. Review.
Cited by
-
Primary Care Antibiotic Prescribing and Infection-Related Hospitalisation.Antibiotics (Basel). 2023 Nov 30;12(12):1685. doi: 10.3390/antibiotics12121685. Antibiotics (Basel). 2023. PMID: 38136719 Free PMC article. Review.
-
Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.Cochrane Database Syst Rev. 2022 Oct 17;10(10):CD010130. doi: 10.1002/14651858.CD010130.pub3. Cochrane Database Syst Rev. 2022. PMID: 36250577 Free PMC article. Review.
-
Descriptive Analysis of Adverse Drug Reactions Reports of the Most Consumed Antibiotics in Portugal, Prescribed for Upper Airway Infections.Antibiotics (Basel). 2022 Apr 2;11(4):477. doi: 10.3390/antibiotics11040477. Antibiotics (Basel). 2022. PMID: 35453228 Free PMC article.
-
Barriers and facilitators to prudent antibiotic prescribing for acute respiratory tract infections: A qualitative study with general practitioners in Malta.PLoS One. 2021 Feb 11;16(2):e0246782. doi: 10.1371/journal.pone.0246782. eCollection 2021. PLoS One. 2021. PMID: 33571265 Free PMC article.
-
The diagnosis of respiratory disease in children using a phone-based cough and symptom analysis algorithm: The smartphone recordings of cough sounds 2 (SMARTCOUGH-C 2) trial design.Contemp Clin Trials. 2021 Feb;101:106278. doi: 10.1016/j.cct.2021.106278. Epub 2021 Jan 12. Contemp Clin Trials. 2021. PMID: 33444779 Free PMC article.
References
-
- Col NF, O’Connor RW. Estimating worldwide current antibiotic usage: report of Task Force 1. Rev Infect Dis. 1987;9(Suppl 3):S232–S243 - PubMed
-
- Halasa NB, Griffin MR, Zhu Y, Edwards KM. Decreased number of antibiotic prescriptions in office-based settings from 1993 to 1999 in children less than five years of age. Pediatr Infect Dis J. 2002;21(11):1023–1028 - PubMed
-
- Finkelstein JA, Stille C, Nordin J, et al. Reduction in antibiotic use among US children, 1996–2000. Pediatrics. 2003;112(3 Pt 1):620–627 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical